
藥物和營養保健干預在青少年心理健康障礙中的代表性和包容性:系統評價和薈萃分析 Representativeness and Inclusivity in Pharmacological and Nutraceutical Interventions in Youth Mental Health Disorders: A Systematic Review and Meta-Analysis ——《自然-心理健康》第4卷第10期,2026年10月—— <Nature / Mental Health>, Volume 4, Issue 10. October 2026 【摘要】隨機對照試驗(RCTs)指導着針對患有精神障礙青少年的治療決策,但人們對其結果的普適性(可推廣性)仍存疑慮。本研究遵循“系統評價和薈萃分析優先報告條目”(PRISMA)指南進行了一項系統評價與薈萃分析(註冊號:CRD42024629137),旨在評估針對患有《精神障礙診斷與統計手冊》(DSM)和/或《國際疾病分類》(ICD)所定義精神障礙的兒童及青少年進行的藥物和營養製劑干預試驗的包容性與代表性。研究按疾病類型進行了隨機效應薈萃分析,並評估了時間趨勢。主要結局指標為RCTs在性別(女性參與者的合併比例)和種族/族裔(種族和族裔群體的分布)方面的代表性;次要結局指標包括對關鍵臨床人群(如自閉症患者、智力障礙者及有自殺風險者)的排除情況。本研究共納入397項RCTs(涉及46,989名參與者;平均年齡10.2 ± 3.1歲),主要針對注意缺陷多動障礙(34.5%)或自閉症譜系障礙(29.7%)。女性參與者占28.3%。僅53.7%的RCTs報告了種族數據;在這些數據中,白人占75.0%,黑人占10.1%,西班牙裔占6.2%,亞裔占2.0%。分別有56.5%和44.3%的試驗將自閉症患者和學習障礙者排除在外;76.0%針對抑鬱症的RCTs排除了有自殺風險的參與者。受精神障礙影響最嚴重的青少年群體與RCTs納入的受試者群體之間,始終存在不匹配現象。包括有色人種、女性及特殊人群在內的部分弱勢群體似乎代表性不足,亟需採取更具包容性的實踐,以支持公平且有效的醫療護理。 [Abstract] Randomized controlled trials (RCTs) guide treatment decisions in youth with mental health disorders, yet concerns remain about their generalizability. Here we conducted a Preferred Reporting Items for Systematic Reviews and Meta-Analyses-compliant systematic review and meta-analysis (CRD42024629137) to assess the inclusivity and representativeness of RCTs on pharmacological and nutraceutical interventions in children and adolescents with Diagnostic and Statistical Manual of Mental Disorders and/or International Classification of Diseases-defined mental disorders. Random-effects meta-analyses were conducted by disorder, and temporal trends were assessed. Primary outcomes were the representativeness of RCTs with respect to sex (pooled proportion of female participants) and race/ethnicity (distribution of racial and ethnic groups); secondary outcomes included the exclusion of key clinical populations (for example, autistic individuals, those with intellectual disability and those with suicide risk). A total of 397 RCTs (46,989 participants; mean age 10.2 ± 3.1 years) were included, mostly targeting attention deficit hyperactivity disorder (34.5%) or autism spectrum disorder (29.7%). Female participants represented 28.3%. Only 53.7% of RCTs reported racial data; 75.0% were white, 10.1% Black, 6.2% Hispanic and 2.0% Asian. Autistic individuals and those with learning disabilities were excluded in 56.5% and 44.3% of trials, respectively; 76.0% of depression RCTs excluded participants at suicide risk. There is a persistent mismatch between the youth most affected by mental health disorders and those included in RCTs. Some vulnerable populations including people of colour, women and special populations seem to be under-represented, requiring more inclusive practice to support equitable and effective care. 論文原文:Claudia Aymerich, Javier Torres-Cortés, Antonio Melillo, et al. (2026). Representativeness and inclusivity in pharmacological and nutraceutical interventions in youth mental health disorders: a systematic review and meta-analysis. Nature / Mental Health, Volume 4, Issue 10, Pages 1592–1603. October 2026. https://doi.org/10.1038/s44220-026-00722-5 (翻譯兼責任編輯:MARY) (需要英文原文的朋友,請聯繫微信:millerdeng95或iacmsp)

|